Fangda represented Jinxin Fertility Group Limited in the top-up placing of 175,000,000 shares of the Company involving a gross proceeds of over HK$1,100 million
Tell others about this press release
The press releases published in this section have been uploaded by law firms. Their content has not been appraised or edited by Law.asia, and no responsibility is taken for the accuracy of the information they contain or any misrepresentation therein. For our independent editorial content, please visit our homepage.
Fangda Partners represented Jinxin Fertility Group Limited (HK stock code: 1951) (the “Company”) in the top-up placing of 175,000,000 shares of the Company at a share price of HK$6.725 each involving a gross proceeds of over HK$1,100 million. The overall coordinator and placing agent in the transaction was Morgan Stanley. The transaction was signed on January 5, 2023 and announced on the same day. The Fangda team on this deal was led by partners Colin Law and Arman Lie, counsel Jonathan Wallenberger, associates Brian Kwok and Lizzie Cheong, and trainee solicitor Cecilia Li. Fangda advised on Hong Kong and US legal aspects of the transaction and prepared for the disclosure and other related documents. It was the second placing that the Company conducted since its listing in June 2019. The aggregate value of all placement transactions of the Company amounted to approximately HK$2,450 million.
Join our mailing list for legal news and alerts
Sign up